Opinions
Jim Cramer - Mad Money
Butterfly Network
BFLY-N
COMMENT
Aug 16, 2021
He knew a doctor he liked BFLY's product, so he thought the stock could be a hit, but the company arrived against too much competition. At least wait for the current stock selling to end.
$10.180
Stock price when the opinion was issued
medical services
It's the ideal tool to help you make quicker, more informed decisions for
managing and tracking your investments.
You might be interested:
RISKY
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research.
BFLY is involved in medical imaging systems where one can connect an ultrasound device to a phone and provide ultrasounds. It is a $432M company with expected top line growth of 20%+ expected for the next few years, although it is not profitable, and is not expected to be profitable for at least a few years. Its balance sheet is decent, and it has $237.8M in cash. It does not generate free cash flow and mostly issues shares to fund its operations. We would view it as a higher-risk company overall.
Unlock Premium - Try 5i Free
medical services